Entrepreneur's Workshop

Keynote Address

CUB Jr. Ballroom
12:30pm on May 8, 2019

Monique Greer


Monique M. Greer
Vice President, Corporate Communications
Seattle Genetics Inc.

Monique Greer has more than 20 years’ strategic communications experience in the biopharmaceutical industry. She joined Seattle Genetics, the largest biotech company in the Pacific Northwest, in 2018 and leads the team responsible for shaping and delivering the company’s story to support its mission to improve the lives of people with cancer. Prior to joining Seattle Genetics, Monique led Corporate Communications & Investor Relations at Cascadian Therapeutics (acquired by Seattle Genetics) where she helped build awareness of the company and lead program in metastatic breast cancer. Monique was fortunate to support two drug launches - from clinical trials to approval in Europe and the U.S. From 2012 to 2016, she led global communications and helped launch a drug for aggressive B-cell non-Hodgkin lymphoma at CTI BioPharma, and from 2008 to 2012 she was involved with the approval and launch of a drug for peripheral T-cell lymphoma while at Allos Therapeutics (acquired by Spectrum Pharmaceuticals). Prior to Allos, Monique consulted with several biopharmaceutical companies while at WCG, a global communications agency in San Francisco. She also built the communications and investor relations function at Dendreon Corporation, and at Heska Corporation, an animal health biotech company. Monique holds a Bachelor of Science degree in Marketing and International Business from Northeastern University, Boston.

Washington State University